Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition

Cell Host & Microbe(2020)10.1016/j.chom.2020.06.020Source: DataRank Database

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition is a research paper published in Cell Host & Microbe (2020). On theSindex it has a DataRank of 10.4. It has been cited 243 times, with 200 citing works in its 1-hop citation network.

N/A

10.4DataRank · unranked

Scored on demand from live citation data

Open Access243 citations · 200 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: bronzeTopics (91)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 8%Citation Network 92%

Base Score Contribution

0.825

From this paper's citation signal

Citation Network Contribution

9.6

From 193 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
The Journal of Heart and Lung Transplantation2021134 citations9 referencesContributes 0.545
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months
American Journal of Transplantation20227 citations5 referencesContributes 0.416
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Science20201,482 citations21 referencesContributes 0.348
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
Emerging Microbes & Infections2020168 citations17 referencesContributes 0.302
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
New England Journal of Medicine20211,490 citations26 referencesContributes 0.281

Authors (23)

Denise Haslwanter ORCID,Robert H. Bortz ORCID,Ariel S. Wirchnianski ORCID,Gorka Lasso ORCID,Olivia Vergnolle

Live enrichment

PubMed:32738193

National Institutes of Health

Grant: 5U19AI142777-04

Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats

National Institutes of Health

Grant: 2T32GM007288-45

Medical Scientist Training Program

National Institutes of Health

Grant: 5R01AI132633-04

Dissecting the receptor-mediated infection mechanisms of hantaviruses

National Institutes of Health

Grant: 5R01AI123654-03

Antibody therapy for pneumococcal disease

National Institutes of Health

Grant: 5R01AI125462-04

Engineered, multispecific antibodies as broad anti-filovirus therapeutics

National Institutes of Health

Grant: 5R21AI141367-03

Plasmodium phospholipase A2s as potential novel drug targets

National Institutes of Health

Grant: 5R01AI143453-03

Antibodies, B cells and resistance to human cryptococcosis

NIAID NIH HHS

Grant: R01 AI123654

NIAID NIH HHS

Grant: R01 AI125462

NIGMS NIH HHS

Grant: T32 GM007288

NIAID NIH HHS

Grant: U19 AI142777

NIAID NIH HHS

Grant: R01 AI132633

NIAID NIH HHS

Grant: F30 AI150055

NIAID NIH HHS

Grant: R21 AI141367

NIAID NIH HHS

Grant: R01 AI143453

bronzeLicense: CC BY NC

publisherhttp://www.cell.com/article/S1931312820303619/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312820303619?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312820303619?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7332447

https://doi.org/10.1101/2020.05.20.105247

Fields of Study

0301 basic medicine03 medical and health sciencesAngiotensin-Converting Enzyme 2AnimalsAntiviral AgentsBetacoronavirusCOVID-19COVID-19 VaccinesCell LineChlorocebus aethiopsCoronavirus InfectionsDrug Evaluation, PreclinicalHost Microbial InteractionsHumansMutationNeutralization TestsPandemicsPeptidyl-Dipeptidase APneumonia, ViralReceptors, VirusRecombination, GeneticSARS-CoV-2Serine EndopeptidasesSpike Glycoprotein, CoronavirusVero CellsVesicular stomatitis Indiana virusViral VaccinesVirus InternalizationVirus ReplicationCOVID-19 Drug Treatment

MeSH Terms

Angiotensin-Converting Enzyme 2AnimalsAntiviral AgentsBetacoronavirusCOVID-19COVID-19 VaccinesCell LineChlorocebus aethiopsCoronavirus InfectionsDrug Evaluation, PreclinicalHost Microbial InteractionsHumansMutationNeutralization TestsPandemicsPeptidyl-Dipeptidase APneumonia, ViralReceptors, VirusRecombination, GeneticSARS-CoV-2Serine EndopeptidasesSpike Glycoprotein, CoronavirusVero CellsVesicular stomatitis Indiana virusViral VaccinesVirus InternalizationVirus ReplicationCOVID-19 Drug Treatment

Keywords

ResourceCOVID-19 VaccinesPneumonia, ViralDrug Evaluation, PreclinicalPeptidyl-Dipeptidase AMicrobiologyAntiviral AgentsArticleCell LineBetacoronavirusNeutralization TestsVirologyChlorocebus aethiopsAnimalsHumansPandemicsRecombination, GeneticHost Microbial InteractionsSARS-CoV-2COVID-19MutationReceptors, VirusParasitologyAngiotensin-Converting Enzyme 2Coronavirus InfectionsACE2VSVantiviral drugsconvalescent plasmaneutralization assayneutralizing antibodyserologysurrogate

Sustainable Development Goals

SDG 3: 3. Good health